Cost-minimization analysis of CHOP, fludarabine and...

Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K.

John Sweetenham, Klaus Hieke, Matthew Kerrigan, Paul Howard, Pamela F. M. Smartt, Ann-Marie McIntyre, Sarah Townshend
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
106
Year:
1999
Language:
english
Pages:
8
DOI:
10.1046/j.1365-2141.1999.01515.x
File:
PDF, 245 KB
english, 1999
Conversion to is in progress
Conversion to is failed